The discussion, featuring Shanghvi alongside Aurobindo Pharma whole-time director Madan Mohan Reddy, Lupin managing director Nilesh Gupta and Zydus Lifesciences managing director Sharvil Patel, focused on a growing consensus: Indian pharma must move up the value chain to develop innovative drugs.
Indian pharma leaders call for collaboration, partnerships to spur innovation
